Epinephrine — Class I drug recall D-0179-2023
Terminated recall by Spectrum Laboratory Products, Inc., reported 2023-02-01, distributed nationwide. Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in les
| Recall number | D-0179-2023 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Spectrum Laboratory Products, Inc., New Brunswick, NJ, United States |
| Recall initiated | 2022-12-19 |
| Classified | 2023-01-25 |
| Reported by FDA | 2023-02-01 |
| Terminated | 2025-08-19 |
| Distributed | Nationwide (US) |
| Countries outside the US | CA |
| Quantity | 1 bottles |
| Lot numbers | 1KG0865 |
| Expiration dates | 2023-03-31 |
Product
Epinephrine (L-Adrenaline), USP, CAS 51-43-4, 1 KG amber glass bottle in a vacuum sealed pouch, Rx only, Repackaged by Spectrum Chemical Mfg. Corp. Gardena, CA 90248; New Brunswick, NJ 08901. Product Code EP130
Reason for recall
Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0179-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.